One‐year clinical and echocardiographic outcomes of direct implantation of a self‐expanding valve
- 12 November 2020
- journal article
- research article
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 98 (3), E403-E411
- https://doi.org/10.1002/ccd.29389
Abstract
Objective To present 1 year clinical and echocardiographic outcomes of the randomized DIRECT (Pre‐dilatation in Transcatheter Aortic Valve Implantation Trial) trial. Background Intermediate‐term data from randomized studies investigating the safety and efficacy of direct implantation are lacking. Methods DIRECT trial randomized 171 consecutive patients with severe aortic stenosis at four tertiary centers to undergo TAVI with the use of self‐expanding prostheses with (pre‐BAV) or without pre‐dilatation (no‐BAV). The primary endpoint was device success according to the VARC‐2 criteria. All patients underwent a clinical and echocardiographic follow‐up at 1 year. All‐cause and cardiac mortality, stroke, heart failure hospitalization, and new pacemaker implantation were recorded. Results At 1 year, four deaths were recorded in pre‐BAV group (4.7%) and three deaths in no‐BAV group (3.5%). There was no difference in Kaplan–Meier plots between the two groups in all‐cause mortality at 1 year (log‐rank p = .72). Similarly, there was no difference in the incidence of permanent pacemaker implantation between the two groups at 1 year (27/67–40.3% in no‐BAV group versus 20/69–29% in pre‐BAV group, log‐rank p = .24). There was no significant difference between pre‐BAV and no BAV group in aortic valve area (1.84 ± 0.39 cm2 vs. 1.85 ± 0.44 cm2, p = .90), mean aortic valve gradient (8.36 ± 5.04 vs. 8.00 ± 4.04 mmHg, p = .65) and moderate or severe paravalvular regurgitation (5–6.6 vs. 4–5.7%, respectively) at 1 year. The same applied independently from the performance of post‐dilatation at baseline. Conclusions Direct, without pre‐dilatation, implantation of a self‐expanding valve has no impact on one‐year clinical and echocardiographic outcomes, independently also from the baseline performance of post‐dilatation.Funding Information
- Medtronic
This publication has 20 references indexed in Scilit:
- Can predilatation in transcatheter aortic valve implantation be omitted? - a prospective randomized studyJournal of Cardiothoracic Surgery, 2016
- Direct Transcatheter Heart Valve Implantation Versus Implantation With Balloon PredilatationCirculation: Cardiovascular Interventions, 2016
- Self-Expanding Transcatheter Aortic Valve Replacement Versus Surgical Valve Replacement in Patients at High Risk for SurgeryCirculation: Cardiovascular Interventions, 2016
- No clinical effect of prosthesis–patient mismatch after transcatheter versus surgical aortic valve replacement in intermediate- and low-risk patients with severe aortic valve stenosis at mid-term follow-up: an analysis from the NOTION trialEuropean Journal of Cardio-Thoracic Surgery, 2016
- One-year outcomes after direct transcatheter aortic valve implantation with a self-expanding bioprosthesis. A two-center international experience.International Journal of Cardiology, 2015
- 2-Year Outcomes in Patients Undergoing Surgical or Self-Expanding Transcatheter Aortic Valve ReplacementJournal of the American College of Cardiology, 2015
- Incidence and Sequelae of Prosthesis-Patient Mismatch in Transcatheter Versus Surgical Valve Replacement in High-Risk Patients With Severe Aortic StenosisJournal of the American College of Cardiology, 2014
- Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document†European Heart Journal, 2012
- Feasibility of Transcatheter Aortic Valve Implantation Without Balloon Pre-Dilation: A Pilot StudyJACC: Cardiovascular Interventions, 2011
- Electrocardiographically Gated Multi–Detector Row CT for Assessment of Valvular Morphology and Calcification in Aortic StenosisRadiology, 2002